Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort in Circulation: Cardiovascular Interventions
Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort, by Drs. Melica, Carasso, Butnaru, Gogorishvili, Metreveli, Modine, Kurashvili, Farkash, Meerkin, has been accepted for publication in Circulation: Cardiovascular Interventions. Background: The AMEND implant is a semi-rigid closed D-shaped annuloplasty ring [...]
Valcare Medical Appoints Two New Members to Board of Directors
WILMINGTON, Del., March 6, 2026 /PRNewswire/ – Valcare Medical, Inc., a pioneer in transcatheter mitral valve repair solutions, today announced the appointment of two new members to its Board of Directors: Jeffrey B. Jump and Jacques Séguin, MD, PhD. These renowned experts in the structural [...]
Paul Sorajja, M.D. discusses the First-in-America Implantation of AMEND Annuloplasty Ring in Mitral Regurgitation
Listen to Dr. Paul Sorajja, Interventional Cardiologist at Banner University Medical Center Phoenix, describe the first implantation of the AMEND annuloplasty ring via a novel trans-septal system designed to help a leaky mitral valve. Video here: New catheter procedure treats leaky heart valves - Arizona [...]
How AMEND™ TMVr Annuloplasty System Is Re-engineering Mitral Valve Repair
Watch DeviceTalks host Tom Salemi interview Steve Sandweg CEO and Dr. David Meerkin CMO as they discuss how Valcare’s AMEND™ TMVr Annuloplasty System is re-engineering mitral valve repair. Register here to gain immediate access to view the webinar recording. Webinar Overview Surgical Annuloplasty has long [...]
Valcare Medical Announces First U.S. Transseptal AMEND™ Implant in Early Feasibility Study
WILMINGTON, Del., February 11, 2026 /PRNewswire/ — Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S. transseptal implantation of its AMEND™ Transcatheter Mitral Valve Repair (TMVr) Annuloplasty System as part of the ongoing AMEND TS Early [...]
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System
HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS). The AMEND™ Trans-Septal [...]
Valcare Medical, Inc. Expands AMEND TS EU Pilot Study to Italy
TAMPA, Fla., July 25, 2024 /PRNewswire/ -- Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, announces the expansion of the AMEND™ TS EU Pilot Study to Italy. The Italian Ministry of Health has approved the extension to include multiple centers throughout Italy, building [...]
Valcare Medical, Inc. Announces Formation of Scientific Advisory Board with Renowned Mitral Valve Experts
TAMPA, Fla., July 2, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced the formation of a Scientific Advisory Board (SAB) comprised of distinguished experts. The SAB will provide expert insight and guidance while helping the Company further advance its research [...]